• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支气管肺泡灌洗液和肺活检组织宏基因组下一代测序在肺隐球菌病诊断中的应用。

Bronchoalveolar lavage fluid and lung biopsy tissue metagenomic next-generation sequencing in the diagnosis of pulmonary cryptococcosis.

机构信息

Department of Respiratory Medicine, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China.

Department of Clinical Laboratory Medicine, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China.

出版信息

Front Cell Infect Microbiol. 2024 Oct 29;14:1446814. doi: 10.3389/fcimb.2024.1446814. eCollection 2024.

DOI:10.3389/fcimb.2024.1446814
PMID:39534702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11554620/
Abstract

OBJECTIVE

To evaluate the diagnostic value of metagenomic next-generation sequencing (mNGS) in pulmonary cryptococcosis (PC) using bronchoalveolar lavage fluid (BALF) and lung biopsy tissue specimens.

METHODS

In this retrospective study, 321 patients diagnosed with lower respiratory tract diseases who underwent mNGS using BALF and LBT samples, between January 2021 and December 2023 were included. Individuals were classified into PC and non-PC groups according to the diagnostic criteria for PC, and conventional fungal cultures were performed. A serum/BALF cryptococcal antigen (CrAg) test was performed in some patients with PC. The diagnostic efficiencies of three methods for PC (mNGS, conventional culture, and CrAg) were compared. Additionally, two mNGS methods were used in this study: original mNGS (OmNGS, testing time from January 2021 to December 2022) and modified mNGS (MmNGS, testing time from January to December 2023). The diagnostic efficiency of the two mNGS methods on PC was simultaneously compared.

RESULTS

Among the 321 patients, 23 (7.2%) had PC and 298 (92.8%) did not. Compared with the composite reference standard for PC diagnosis, the sensitivity, specificity, and accuracy of mNGS for PC were 78.3% (95% confidence interval [CI], 55.8%-91.7%), 98.7% (95% CI, 96.4%-99.6%), and 97.2% (95% CI, 94.7%-98.7%), respectively. The sensitivity of mNGS was similar to that of CrAg (80.0%, 12/15) ( > 0.05). The diagnostic sensitivity of both mNGS and CrAg was higher than that of conventional culture (35.0%, 7/20) ( = 0.006, = 0.016), and the combined detection of mNGS and CrAg further improved the diagnostic sensitivity of PC (93.3%, 14/15). The area under the receiver operating characteristic curve of mNGS was superior to that of conventional culture (0.885 vs. 0.675). In addition, the diagnostic sensitivity of PC was higher than that of OmNGS ( = 0.046).

CONCLUSION

The sensitivity of mNGS is better than that of conventional culture. The combination of mNGS and CrAg improves the testing sensitivity of . MmNGS could further improve the detection of . Conventional PC detection methods are indispensable and mNGS can be used as a rapid and accurate auxiliary diagnostic method for PC.

摘要

目的

评估宏基因组下一代测序(mNGS)在支气管肺泡灌洗液(BALF)和肺活检组织标本中对肺隐球菌病(PC)的诊断价值。

方法

在这项回顾性研究中,纳入了 2021 年 1 月至 2023 年 12 月期间,因下呼吸道疾病接受 mNGS 检测的 321 例患者。根据 PC 的诊断标准,将患者分为 PC 组和非 PC 组,并进行常规真菌培养。部分 PC 患者进行了血清/支气管肺泡灌洗液隐球菌抗原(CrAg)检测。比较了 mNGS、常规培养和 CrAg 三种方法对 PC 的诊断效率。此外,本研究采用了两种 mNGS 方法:原始 mNGS(OmNGS,检测时间为 2021 年 1 月至 2022 年 12 月)和改良 mNGS(MmNGS,检测时间为 2023 年 1 月至 12 月)。同时比较了两种 mNGS 方法对 PC 的诊断效率。

结果

321 例患者中,23 例(7.2%)患有 PC,298 例(92.8%)未患有 PC。与 PC 诊断的综合参考标准相比,mNGS 对 PC 的敏感度、特异度和准确度分别为 78.3%(95%CI,55.8%-91.7%)、98.7%(95%CI,96.4%-99.6%)和 97.2%(95%CI,94.7%-98.7%)。mNGS 的灵敏度与 CrAg(80.0%,12/15)相似(>0.05)。mNGS 和 CrAg 的诊断灵敏度均高于常规培养(35.0%,7/20)(=0.006,=0.016),mNGS 和 CrAg 的联合检测进一步提高了 PC 的诊断灵敏度(93.3%,14/15)。mNGS 的受试者工作特征曲线下面积优于常规培养(0.885 比 0.675)。此外,PC 的 mNGS 诊断灵敏度高于 OmNGS(=0.046)。

结论

mNGS 的灵敏度优于常规培养。mNGS 和 CrAg 的联合检测提高了检测的灵敏度。MmNGS 可以进一步提高对的检测。传统的 PC 检测方法不可或缺,mNGS 可作为 PC 的快速、准确的辅助诊断方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc0/11554620/2d08f549b817/fcimb-14-1446814-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc0/11554620/d2d50bf8050f/fcimb-14-1446814-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc0/11554620/d4fd6426cd28/fcimb-14-1446814-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc0/11554620/7d2df3c23ca7/fcimb-14-1446814-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc0/11554620/2d08f549b817/fcimb-14-1446814-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc0/11554620/d2d50bf8050f/fcimb-14-1446814-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc0/11554620/d4fd6426cd28/fcimb-14-1446814-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc0/11554620/7d2df3c23ca7/fcimb-14-1446814-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc0/11554620/2d08f549b817/fcimb-14-1446814-g004.jpg

相似文献

1
Bronchoalveolar lavage fluid and lung biopsy tissue metagenomic next-generation sequencing in the diagnosis of pulmonary cryptococcosis.支气管肺泡灌洗液和肺活检组织宏基因组下一代测序在肺隐球菌病诊断中的应用。
Front Cell Infect Microbiol. 2024 Oct 29;14:1446814. doi: 10.3389/fcimb.2024.1446814. eCollection 2024.
2
Pulmonary Cryptococcosis Diagnosed by Metagenomic Next-Generation Sequencing in a Young Patient With Normal Immune Function: A Case Report.肺部隐球菌病通过免疫功能正常的年轻患者的宏基因组下一代测序诊断:病例报告。
Front Public Health. 2022 Jul 22;10:942282. doi: 10.3389/fpubh.2022.942282. eCollection 2022.
3
Performance of Metagenomic Next-Generation Sequencing for the Diagnosis of Cryptococcal Meningitis in HIV-Negative Patients.宏基因组下一代测序在诊断 HIV 阴性患者隐球菌性脑膜炎中的性能。
Front Cell Infect Microbiol. 2022 Apr 21;12:831959. doi: 10.3389/fcimb.2022.831959. eCollection 2022.
4
[Diagnostic value of the combinations of bronchoalveolar lavage fluid pathogen detection and cryptococcal antigen test in pulmonary cryptococcosis].支气管肺泡灌洗液体病原体检测与隐球菌抗原检测联合应用在肺隐球菌病中的诊断价值
Zhonghua Jie He He Hu Xi Za Zhi. 2021 Aug 12;44(8):711-716. doi: 10.3760/cma.j.cn112147-20201123-01113.
5
Diagnostic accuracy of metagenomic next-generation sequencing for cryptococcosis in immunocompetent and immunocompromised patients.免疫功能正常和免疫功能低下患者隐球菌病的宏基因组下一代测序的诊断准确性。
Front Cell Infect Microbiol. 2022 Oct 20;12:997256. doi: 10.3389/fcimb.2022.997256. eCollection 2022.
6
Metagenomic next-generation sequencing contributes to the diagnosis of mixed pulmonary infection: a case report.宏基因组下一代测序有助于混合性肺部感染的诊断:一例报告。
Ann Clin Microbiol Antimicrob. 2022 Nov 24;21(1):52. doi: 10.1186/s12941-022-00545-z.
7
A single-center, retrospective study of hospitalized patients with lower respiratory tract infections: clinical assessment of metagenomic next-generation sequencing and identification of risk factors in patients.一项关于下呼吸道感染住院患者的单中心回顾性研究:宏基因组下一代测序的临床评估及患者风险因素的识别。
Respir Res. 2024 Jun 20;25(1):250. doi: 10.1186/s12931-024-02887-y.
8
Clinical utility of metagenomic next-generation sequencing in the diagnosis of invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease patients in the intensive care unit.宏基因组下一代测序在重症监护病房慢性阻塞性肺疾病急性加重患者侵袭性肺曲霉病诊断中的临床应用。
Front Cell Infect Microbiol. 2024 Jul 12;14:1397733. doi: 10.3389/fcimb.2024.1397733. eCollection 2024.
9
The value of metagenomic next-generation sequencing with different nucleic acid extracting methods of cell-free DNA or whole-cell DNA in the diagnosis of non-neutropenic pulmonary aspergillosis.不同核酸提取方法(细胞游离 DNA 或全细胞 DNA)的宏基因组二代测序在诊断非中性粒细胞减少性肺部曲霉病中的价值。
Front Cell Infect Microbiol. 2024 Jul 29;14:1398190. doi: 10.3389/fcimb.2024.1398190. eCollection 2024.
10
Clinical utility of metagenomic next-generation sequencing on bronchoalveolar lavage fluid in diagnosis of lower respiratory tract infections.宏基因组下一代测序在支气管肺泡灌洗液中下呼吸道感染诊断中的临床应用。
BMC Pulm Med. 2024 Aug 29;24(1):422. doi: 10.1186/s12890-024-03237-w.

引用本文的文献

1
Overcoming the Diagnostic Challenges in Cutaneous Cryptococcosis Caused by Cryptococcus neoformans: A Case Study Utilizing Metagenomic Next-Generation Sequencing.克服新型隐球菌引起的皮肤隐球菌病的诊断挑战:一项利用宏基因组下一代测序的病例研究
Mycopathologia. 2025 Jul 16;190(4):64. doi: 10.1007/s11046-025-00973-3.

本文引用的文献

1
Clinical application value of metagenome next-generation sequencing in pulmonary diffuse exudative lesions: a retrospective study.宏基因组下一代测序在肺部弥漫渗出性病变中的临床应用价值:一项回顾性研究。
Front Cell Infect Microbiol. 2024 May 8;14:1367885. doi: 10.3389/fcimb.2024.1367885. eCollection 2024.
2
Enhancing Clinical Utility: Utilization of International Standards and Guidelines for Metagenomic Sequencing in Infectious Disease Diagnosis.提高临床实用性:在传染病诊断中应用宏基因组测序的国际标准和指南。
Int J Mol Sci. 2024 Mar 15;25(6):3333. doi: 10.3390/ijms25063333.
3
Case Report: Pneumonia Caused by and Co-Infection.
病例报告:由[具体病菌名称1]和[具体病菌名称2]共同感染引起的肺炎
Infect Drug Resist. 2024 Mar 6;17:845-849. doi: 10.2147/IDR.S445920. eCollection 2024.
4
COVID-19 in pulmonary critically ill patients: metagenomic identification of fungi and characterization of pathogenic microorganisms.肺危重症 COVID-19 患者:真菌的宏基因组鉴定及病原微生物特征。
Front Cell Infect Microbiol. 2024 Feb 20;13:1220012. doi: 10.3389/fcimb.2023.1220012. eCollection 2023.
5
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM.全球隐球菌病诊断和管理指南:欧洲癌症研究与治疗组织和国际系统性真菌感染学会与美国微生物学会合作开展的一项倡议。
Lancet Infect Dis. 2024 Aug;24(8):e495-e512. doi: 10.1016/S1473-3099(23)00731-4. Epub 2024 Feb 9.
6
Disseminated cryptococcosis in a patient with idiopathic CD4 + T lymphocytopenia presenting as prostate and adrenal nodules: diagnosis from pathology and mNGS, a case report.特发性 CD4+T 淋巴细胞减少症患者播散性隐球菌病表现为前列腺和肾上腺结节:病理和 mNGS 诊断,一例报告。
BMC Infect Dis. 2024 Jan 2;24(1):26. doi: 10.1186/s12879-023-08926-1.
7
Metagenomic next generation sequencing of bronchoalveolar lavage samples for the diagnosis of lower respiratory tract infections: A systematic review and meta-analysis.用于诊断下呼吸道感染的支气管肺泡灌洗样本宏基因组下一代测序:一项系统评价和荟萃分析
Heliyon. 2023 Dec 6;10(1):e23188. doi: 10.1016/j.heliyon.2023.e23188. eCollection 2024 Jan 15.
8
Clinical Application and Evaluation of Metagenomic Next-Generation Sequencing for Lower Respiratory Tract Infections and Human Tumor Screening.宏基因组下一代测序在下呼吸道感染及人类肿瘤筛查中的临床应用与评估
Int J Gen Med. 2023 Dec 7;16:5763-5777. doi: 10.2147/IJGM.S437800. eCollection 2023.
9
Comparison of different criteria of metagenomic next-generation sequencing for the diagnosis of invasive pulmonary aspergillosis in critically ill patients.比较不同宏基因组下一代测序标准对危重症患者侵袭性肺曲霉病的诊断价值。
Diagn Microbiol Infect Dis. 2024 Feb;108(2):116135. doi: 10.1016/j.diagmicrobio.2023.116135. Epub 2023 Nov 13.
10
Diagnostic Performance of Metagenomic Next-Generation Sequencing in Central Nervous System Cryptococcosis Using Cerebrospinal Fluid.基于脑脊液的宏基因组下一代测序技术在中枢神经系统隐球菌病中的诊断效能
Infect Drug Resist. 2023 Sep 13;16:6175-6183. doi: 10.2147/IDR.S425463. eCollection 2023.